Report Content
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Companion diagnostics industry 3600 synopsis, 2014 - 2025
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Disease indication trends
2.1.4. Technology trends
2.1.5. End-use
2.1.6. Regional trends
Chapter 3. Companion Diagnostics Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2014 – 2025
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Increasing drug diagnostic co-development
3.3.1.2. Improving regulatory scenario
3.3.1.3. Growing incidences of adverse drug reaction
3.3.1.4. Increasing prevalence of cancer globally
3.3.2. Industry pitfalls & challenges
3.3.2.1. High cost of companion diagnostics test in developing and underdeveloped regions
3.4. Growth potential analysis
3.4.1. By Product
3.4.2. By Disease indication
3.4.3. By Technology
3.4.4. By End-use
3.5. Porter’s analysis
3.6. Competitive landscape, 2018
3.6.1. Strategy dashboard
3.7. PESTEL analysis
Chapter 4. Companion Diagnostics Market, By Product
4.1. Key segment trends
4.2. Instruments
4.2.1. Market size, by region, 2014-2025 (USD Million)
4.3. Consumables
4.3.1. Market size, by region, 2014-2025 (USD Million)
4.4. Services
4.4.1. Market size, by region, 2014-2025 (USD Million)
Chapter 5. Companion Diagnostics Market, By Disease Indication
5.1. Key segment trends
5.2. Breast cancer
5.2.1. Market size, by region, 2014-2025 (USD Million)
5.3. Lung cancer
5.3.1. Market size, by region, 2014-2025 (USD Million)
5.4. Colorectal cancer
5.4.1. Market size, by region, 2014-2025 (USD Million)
5.5. Skin cancer
5.5.1. Market size, by region, 2014-2025 (USD Million)
5.6. Others
5.6.1. Market size, by region, 2014-2025 (USD Million)
Chapter 6. Companion Diagnostics Market, By Technology
6.1. Key segment trends
6.2. Immunohistochemistry
6.2.1. Market size, by region, 2014-2025 (USD Million)
6.3. In Situ Hybridization
6.3.1. Market size, by region, 2014-2025 (USD Million)
6.4. Polymerase Chain Reaction
6.4.1. Market size, by region, 2014-2025 (USD Million)
6.5. Genetic Sequencing
6.5.1. Market size, by region, 2014-2025 (USD Million)
6.6. Others
6.6.1. Market size, by region, 2014-2025 (USD Million)
Chapter 7. Companion Diagnostics Market, By End-use
7.1. Key segment trends
7.2. Hospitals
7.2.1. Market size, by region, 2014-2025 (USD Million)
7.3. Diagnostic laboratories
7.3.1. Market size, by region, 2014-2025 (USD Million)
7.4. Others
7.4.1. Market size, by region, 2014-2025 (USD Million)
Chapter 8. Companion Diagnostics Market, By Region
8.1. Key regional trends
8.2. North America
8.2.1. Market size, by country, 2014-2025 (USD Million)
8.2.2. Market size, by product, 2014-2025 (USD Million)
8.2.3. Market size, by disease indication, 2014-2025 (USD Million)
8.2.4. Market size, by technology, 2014-2025 (USD Million)
8.2.5. Market size, by end-use, 2014-2025 (USD Million)
8.2.6. U.S.
8.2.6.1. Market size, by product, 2014-2025 (USD Million)
8.2.6.2. Market size, by disease indication, 2014-2025 (USD Million)
8.2.6.3. Market size, by technology, 2014-2025 (USD Million)
8.2.6.4. Market size, by end-use, 2014-2025 (USD Million)
8.2.7. Canada
8.2.7.1. Market size, by product, 2014-2025 (USD Million)
8.2.7.2. Market size, by disease indication, 2014-2025 (USD Million)
8.2.7.3. Market size, by technology, 2014-2025 (USD Million)
8.2.7.4. Market size, by end-use, 2014-2025 (USD Million)
8.3. Europe
8.3.1. Market size, by country, 2014-2025 (USD Million)
8.3.2. Market size, by product, 2014-2025 (USD Million)
8.3.3. Market size, by disease indication, 2014-2025 (USD Million)
8.3.4. Market size, by technology, 2014-2025 (USD Million)
8.3.5. Market size, by end-use, 2014-2025 (USD Million)
8.3.6. Germany
8.3.6.1. Market size, by product, 2014-2025 (USD Million)
8.3.6.2. Market size, by disease indication, 2014-2025 (USD Million)
8.3.6.3. Market size, by technology, 2014-2025 (USD Million)
8.3.6.4. Market size, by end-use, 2014-2025 (USD Million)
8.3.7. UK
8.3.7.1. Market size, by product, 2014-2025 (USD Million)
8.3.7.2. Market size, by disease indication, 2014-2025 (USD Million)
8.3.7.3. Market size, by technology, 2014-2025 (USD Million)
8.3.7.4. Market size, by end-use, 2014-2025 (USD Million)
8.3.8. France
8.3.8.1. Market size, by product, 2014-2025 (USD Million)
8.3.8.2. Market size, by disease indication, 2014-2025 (USD Million)
8.3.8.3. Market size, by technology, 2014-2025 (USD Million)
8.3.8.4. Market size, by end-use, 2014-2025 (USD Million)
8.3.9. Italy
8.3.9.1. Market size, by product, 2014-2025 (USD Million)
8.3.9.2. Market size, by disease indication, 2014-2025 (USD Million)
8.3.9.3. Market size, by technology, 2014-2025 (USD Million)
8.3.9.4. Market size, by end-use, 2014-2025 (USD Million)
8.3.10. Spain
8.3.10.1. Market size, by product, 2014-2025 (USD Million)
8.3.10.2. Market size, by disease indication, 2014-2025 (USD Million)
8.3.10.3. Market size, by technology, 2014-2025 (USD Million)
8.3.10.4. Market size, by end-use, 2014-2025 (USD Million)
8.4. Asia Pacific
8.4.1. Market size, by country, 2014-2025 (USD Million)
8.4.2. Market size, by product, 2014-2025 (USD Million)
8.4.3. Market size, by disease indication, 2014-2025 (USD Million)
8.4.4. Market size, by technology, 2014-2025 (USD Million)
8.4.5. Market size, by end-use, 2014-2025 (USD Million)
8.4.6. India
8.4.6.1. Market size, by product, 2014-2025 (USD Million)
8.4.6.2. Market size, by disease indication, 2014-2025 (USD Million)
8.4.6.3. Market size, by technology, 2014-2025 (USD Million)
8.4.6.4. Market size, by end-use, 2014-2025 (USD Million)
8.4.7. China
8.4.7.1. Market size, by product, 2014-2025 (USD Million)
8.4.7.2. Market size, by disease indication, 2014-2025 (USD Million)
8.4.7.3. Market size, by technology, 2014-2025 (USD Million)
8.4.7.4. Market size, by end-use, 2014-2025 (USD Million)
8.4.7.5.
8.4.8. Japan
8.4.8.1. Market size, by product, 2014-2025 (USD Million)
8.4.8.2. Market size, by disease indication, 2014-2025 (USD Million)
8.4.8.3. Market size, by technology, 2014-2025 (USD Million)
8.4.8.4. Market size, by end-use, 2014-2025 (USD Million)
8.4.9. Australia
8.4.9.1. Market size, by product, 2014-2025 (USD Million)
8.4.9.2. Market size, by disease indication, 2014-2025 (USD Million)
8.4.9.3. Market size, by technology, 2014-2025 (USD Million)
8.4.9.4. Market size, by end-use, 2014-2025 (USD Million)
8.5. Latin America
8.5.1. Market size, by country, 2014-2025 (USD Million)
8.5.2. Market size, by product, 2014-2025 (USD Million)
8.5.3. Market size, by disease indication, 2014-2025 (USD Million)
8.5.4. Market size, by technology, 2014-2025 (USD Million)
8.5.5. Market size, by end-use, 2014-2025 (USD Million)
8.5.6. Brazil
8.5.6.1. Market size, by product, 2014-2025 (USD Million)
8.5.6.2. Market size, by disease indication, 2014-2025 (USD Million)
8.5.6.3. Market size, by technology, 2014-2025 (USD Million)
8.5.6.4. Market size, by end-use, 2014-2025 (USD Million)
8.5.7. Mexico
8.5.7.1. Market size, by product, 2014-2025 (USD Million)
8.5.7.2. Market size, by disease indication, 2014-2025 (USD Million)
8.5.7.3. Market size, by technology, 2014-2025 (USD Million)
8.5.7.4. Market size, by end-use, 2014-2025 (USD Million)
8.6. Middle East & Africa
8.6.1. Market size, by country, 2014-2025 (USD Million)
8.6.2. Market size, by product, 2014-2025 (USD Million)
8.6.3. Market size, by disease indication, 2014-2025 (USD Million)
8.6.4. Market size, by technology, 2014-2025 (USD Million)
8.6.5. Market size, by end-use, 2014-2025 (USD Million)
8.6.6. South Africa
8.6.6.1. Market size, by product, 2014-2025 (USD Million)
8.6.6.2. Market size, by disease indication, 2014-2025 (USD Million)
8.6.6.3. Market size, by technology, 2014-2025 (USD Million)
8.6.6.4. Market size, by end-use, 2014-2025 (USD Million)
8.6.7. Saudi Arabia
8.6.7.1. Market size, by product, 2014-2025 (USD Million)
8.6.7.2. Market size, by disease indication, 2014-2025 (USD Million)
8.6.7.3. Market size, by technology, 2014-2025 (USD Million)
8.6.7.4. Market size, by end-use, 2014-2025 (USD Million)
Chapter 9. Company Profiles
9.1. Abbott
9.1.1. Business overview
9.1.2. Financial data
9.1.3. Product landscape
9.1.4. Strategic outlook
9.1.5. SWOT analysis
9.2. Agilent Technologies
9.2.1. Business overview
9.2.2. Financial data
9.2.3. Product landscape
9.2.4. Strategic outlook
9.2.5. SWOT analysis
9.3. bioMérieux
9.3.1. Business overview
9.3.2. Financial data
9.3.3. Product landscape
9.3.4. Strategic outlook
9.3.5. SWOT analysis
9.4. Foundation Medicine
9.4.1. Business overview
9.4.2. Financial data
9.4.3. Product landscape
9.4.4. Strategic outlook
9.4.5. SWOT analysis
9.5. Illumina
9.5.1. Business overview
9.5.2. Financial data
9.5.3. Product landscape
9.5.4. Strategic outlook
9.5.5. SWOT analysis
9.6. MolecularMD (ICON)
9.6.1. Business overview
9.6.2. Financial data
9.6.3. Product landscape
9.6.4. Strategic outlook
9.6.5. SWOT analysis
9.7. Myriad Genetic Laboratories
9.7.1. Business overview
9.7.2. Financial data
9.7.3. Product landscape
9.7.4. Strategic outlook
9.7.5. SWOT analysis
9.8. Johnson & Johnson
9.8.1. Business overview
9.8.2. Financial data
9.8.3. Product landscape
9.8.4. Strategic outlook
9.8.5. SWOT analysis
9.9. Qiagen
9.9.1. Business overview
9.9.2. Financial data
9.9.3. Product landscape
9.9.4. Strategic outlook
9.9.5. SWOT analysis
9.10. Roche
9.10.1. Business overview
9.10.2. Financial data
9.10.3. Product landscape
9.10.4. Strategic outlook
9.10.5. SWOT analysis
9.11. Thermo Fisher Scientific
9.11.1. Business overview
9.11.2. Financial data
9.11.3. Product landscape
9.11.4. Strategic outlook
9.11.5. SWOT analysis
9.12. Arup Laboratories
9.12.1. Business overview
9.12.2. Financial data
9.12.3. Product landscape
9.12.4. Strategic outlook
9.12.5. SWOT analysis
